Business

Your AI Strategy Needs to Go Beyond Efficiency
Technology & Trends Your AI Strategy Needs to Go Beyond Efficiency

With a wealth of experience in Insurtech and AI-driven risk management, Simon Glairy is a leading voice guiding the insurance industry through its digital transformation. He joins us to cut through the hype and discuss how insurers can move beyond viewing AI as a buzzword and start implementing it

Is AM Specialty's UK Entry a Vote of Confidence?
Regulatory & Compliance Is AM Specialty's UK Entry a Vote of Confidence?

AM Specialty Insurance Company (UK), the British subsidiary of the wider AM Specialty Insurance Group, has officially received regulatory authorization from the United Kingdom's Prudential Regulation Authority (PRA) and Financial Conduct Authority (FCA). This pivotal development not only marks a

Will Drone Strikes Spark a Wider War at Sea?
Insurance Will Drone Strikes Spark a Wider War at Sea?

A recent series of audacious drone attacks targeting Russia's "shadow fleet" of oil tankers has sent powerful shockwaves through the global maritime insurance industry, causing war risk premiums to skyrocket and signaling a perilous new phase in international naval tensions. The financial

Can a Direct-Pay Model Fix US Healthcare?
Insurance Can a Direct-Pay Model Fix US Healthcare?

Navigating the American healthcare system has become an increasingly complex and frustrating experience for millions, defined by opaque pricing, restrictive insurance networks, and the constant threat of surprise medical bills. In response to this widespread dissatisfaction, a fundamentally

What Is the Strategy Behind This Financial Mega-Deal?
Insurance What Is the Strategy Behind This Financial Mega-Deal?

A complex and powerful strategic maneuver is reshaping the landscape where asset management and insurance intersect, driven by two interconnected, high-value transactions involving Hildene Capital Management, SILAC, Inc., and Jefferies Financial Group. The core of this financial choreography is a

China Expands Insurance Coverage for Alzheimer's Drug Leqembi
Insurance China Expands Insurance Coverage for Alzheimer's Drug Leqembi

In a landmark move poised to reshape Alzheimer's disease management for millions, China has formally included the innovative treatment Leqembi (lecanemab) in its newly established "Commercial Insurance Innovative Drug List." This strategic decision, announced by BioArctic's partner Eisai,

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later